Patents by Inventor Sharon Bowen

Sharon Bowen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11922629
    Abstract: Various example embodiments are described in which an anisotropic encoder-decoder convolutional neural network architecture is employed to process multiparametric magnetic resonance images for the generation of cancer predication maps. In some example embodiments, a simplified anisotropic encoder-decoder convolutional neural network architecture may include an encoder portion that is deeper than a decoder portion. In some example embodiments, simplified network architectures may be combined with test-time-augmentation in order to facilitate training and testing with a minimal number of test subjects.
    Type: Grant
    Filed: December 11, 2019
    Date of Patent: March 5, 2024
    Assignee: NOVA SCOTIA HEALTH AUTHORITY
    Inventors: Alessandro Guida, David Hoar, Peter Lee, Steve Patterson, Sharon Clarke, Chris Bowen
  • Patent number: 11529363
    Abstract: Provided herein are methods for treating cancers (e.g., inflammatory myofibroblastic tumor, anaplastic large cell lymphoma, and neuroblastoma) in pediatric patients using brigatinib, as monotherapy or combination therapy with one or more second therapeutic agents.
    Type: Grant
    Filed: March 18, 2019
    Date of Patent: December 20, 2022
    Inventors: Sharon Bowen, Michael Hanley, David Kerstein, Karthik Venkatakrishnan
  • Publication number: 20210000845
    Abstract: Provided herein are methods for treating cancers (e.g., inflammatory myofibroblastic tumor, anaplastic large cell lymphoma, and neuroblastoma) in pediatric patients using brigatinib, as monotherapy or combination therapy with one or more second therapeutic agents.
    Type: Application
    Filed: March 18, 2019
    Publication date: January 7, 2021
    Inventors: Sharon Bowen, Michael Hanley, David Kerstein, Karthik Venkatakrishnan